(917) 310-3371
Spravato nasal spray has been making headlines as a promising new treatment for depression. This medication, also known as esketamine, was approved by the FDA in 2019 and has been hailed as a breakthrough for patients with treatment-resistant depression. However, recent safety concerns have arisen surrounding the use of Spravato nasal spray, leaving many patients and healthcare providers wondering about its risks and benefits.
What is Spravato?
Spravato is a nasal spray medication that contains esketamine, a variation of the anesthetic and party drug ketamine. It works by blocking certain receptors in the brain, leading to an increase in the levels of neurotransmitters like serotonin and norepinephrine, which are associated with mood regulation. It is intended for use in patients who have not responded to other antidepressant medications.
What are the safety concerns surrounding Spravato?
While Spravato has shown promise in treating depression, there are some safety concerns that have arisen with its use. One of the most significant risks associated with the medication is the potential for abuse and addiction. Because esketamine is a variation of ketamine, it has a potential for abuse and can be addictive if misused.
Another safety concern is the potential for serious side effects. The FDA requires Spravato to carry a black box warning, the agency’s strongest warning, due to the risk of sedation, dissociation, and the potential for abuse and misuse. Some patients have reported feeling disoriented or “out of touch with reality” after using the medication. There have also been reports of suicidal ideation and behavior in patients using the medication.
What are the potential benefits of Spravato?
Despite the safety concerns, Spravato has shown promise in treating patients with treatment-resistant depression. In clinical trials, the medication was found to be effective in reducing symptoms of depression and suicidal ideation. It may be a valuable option for patients who have not responded to other antidepressant medications.
What should patients and healthcare providers consider before using Spravato?
Patients and healthcare providers should carefully consider the potential risks and benefits of Spravato before using it as a treatment option. Patients should disclose any history of substance abuse or addiction, as well as any mental health conditions, to their healthcare provider before starting treatment with Spravato. Healthcare providers should monitor patients closely for any signs of abuse, addiction, or suicidal ideation while using the medication.
Conclusion
Spravato nasal spray has the potential to be a valuable treatment option for patients with treatment-resistant depression. However, it is important to carefully consider the potential risks and benefits of the medication before using it. Patients and healthcare providers should work together to determine if Spravato is the right treatment option for the patient, taking into account the patient’s medical history, current medications, and other factors. It is also important to closely monitor patients for any signs of abuse, addiction, or suicidal ideation while using the medication.
Book an appointment at Nao Medical
If you are considering Spravato as a treatment option for depression, Nao Medical can help. Our team of healthcare providers is dedicated to providing high-quality, affordable care, and can work with you to determine the best treatment plan for your individual needs. Book an appointment with us today to learn more.
FAQs
What is Spravato?
Spravato is a nasal spray medication that contains esketamine, a variation of the anesthetic and party drug ketamine.
What are the safety concerns surrounding Spravato?
The safety concerns associated with Spravato include the potential for abuse and addiction, as well as serious side effects like sedation, dissociation, and suicidal ideation and behavior.
What are the potential benefits of Spravato?
Spravato has shown promise in treating patients with treatment-resistant depression, reducing symptoms of depression and suicidal ideation.
What should patients and healthcare providers consider before using Spravato?
Before using Spravato, patients and healthcare providers should carefully consider the potential risks and benefits of the medication, including the potential for abuse, addiction, and serious side effects like sedation, dissociation, and suicidal ideation and behavior.
Is Spravato covered by insurance?
Spravato is covered by many insurance plans, including Medicare and Medicaid. Nao Medical accepts a variety of insurance plans, and our team can work with you to determine your coverage options.
Can I get Spravato at Nao Medical?
Yes, Nao Medical offers Spravato as a treatment option for depression. Book an appointment with us today to learn more.
At Nao Medical, we are committed to providing high-quality, affordable healthcare to our patients. If you are considering Spravato as a treatment option for depression, we can help. Book an appointment with us today to learn more about our services and how we can help you achieve total whole body and mind care
